Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-25-065860
Filing Date
2025-05-07
Accepted
2025-05-07 17:00:10
Documents
11
Period of Report
2025-03-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A hura-20250307.htm   iXBRL 8-K/A 52865
  Complete submission text file 0000950170-25-065860.txt   178637

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20250307.xsd EX-101.SCH 31847
14 EXTRACTED XBRL INSTANCE DOCUMENT hura-20250307_htm.xml XML 5252
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37823 | Film No.: 25922517
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)